At Autism Alignment, we are dedicated to empowering and supporting parents of children with Autism by providing them with free, accessible, and comprehensive resources.
Neurotech’s Phase 2/3 autism trial meets primary endpoint
Neurotech International (ASX:NTI) reports positive outcomes from its Phase 2/3 NTIASD2 clinical trial targeting children diagnosed with ASD.